These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 31518706)

  • 1. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review.
    Thakkar S; Sharma D; Kalia K; Tekade RK
    Acta Biomater; 2020 Jan; 101():43-68. PubMed ID: 31518706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy.
    Tang L; Mei Y; Shen Y; He S; Xiao Q; Yin Y; Xu Y; Shao J; Wang W; Cai Z
    Int J Nanomedicine; 2021; 16():5811-5829. PubMed ID: 34471353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment and nanotherapeutics: intruding the tumor fort.
    Ravi Kiran AVVV; Kusuma Kumari G; Krishnamurthy PT; Khaydarov RR
    Biomater Sci; 2021 Nov; 9(23):7667-7704. PubMed ID: 34673853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
    Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities.
    Nezhadi S; Saadat E; Handali S; Dorkoosh F
    J Drug Target; 2021 Feb; 29(2):185-198. PubMed ID: 32772739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsive Role of Nanomedicine in the Tumor Microenvironment and Cancer Drug Resistance.
    Sa P; Sahoo SK; Dilnawaz F
    Curr Med Chem; 2023; 30(29):3335-3355. PubMed ID: 36154585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy.
    Qiao Y; Wan J; Zhou L; Ma W; Yang Y; Luo W; Yu Z; Wang H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1527. PubMed ID: 29726115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
    Zhang Y; Ho SH; Li B; Nie G; Li S
    Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular and extracellular matrix remodeling by physical approaches to improve drug delivery at the tumor site.
    Gouarderes S; Mingotaud AF; Vicendo P; Gibot L
    Expert Opin Drug Deliv; 2020 Dec; 17(12):1703-1726. PubMed ID: 32838565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.
    Caster JM; Wang AZ
    Ther Deliv; 2017 Aug; 8(9):791-803. PubMed ID: 28825397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
    Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
    Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
    Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.